![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 13, 2013 4:37:37 PM
It is sad to see people we have never heard of or heard from bashing us. Based on what? They have never even asked us a question. Shareholder relations can be reached at MCETinvestor@MultiCellTech.com if you have a question or comment. Meanwhile, please know that what an R & D/pre-clinical stage company like ours does is mostly going to be behind the scenes. We don't feel the need to report on the fact that we all work every day. Investor relations is still here, the office manager is still on duty. Mr. Newmin, known most of his working life as a turnaround expert, is still heading the company. The board of directors is still on board. Management is interfacing regularly with the accountants and auditors who are working for us diligently for every quarter's reporting. MultiCell Technologies has intellectual property lawyers protecting the patent rights on our pipeline therapeutics. MultiCell and the Xenogenics subsidiary have research scientists. The board, management and our consultants are regularly communicating with each other and the scientists on what we are doing and what we should be planning.
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM